US-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...

Nevro (NYSE:NVRO) announced today that it received CE mark in Europe for its HFX iQ spinal cord stimulation (SCS) system.

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...

In an episode of ABC's "Four Corners" this week, the use of spinal cord stimulators for chronic back pain was brought into question. Spinal cord stimulators are devices implanted surgically which ...

Inceptiv is a small device, implanted in the lower torso with leads to the spinal cord, that provides responsive counter-stimulation to relieve chronic pain. The device was approved by the FDA in ...

Epidural stimulation is an experimental therapy that has the potential to help individuals with spinal cord injuries ... a GlobalData owned brand. The information on this site has been included ...

There's a new version of a spinal cord stimulator that is increasing the quality of life for patients, like Kim Arledge. She has been suffering with back pain for almost 15 years. Medications and ...

The global spinal cord stimulators market is on a robust growth trajectory, poised to reach an impressive valuation of USD 5,441.4 million by 2033. Currently valued at USD 2,702.7 million in 2023, the ...

Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.